Administrative Core
Administrative Core
批准号:
10097986
负责人:
Barton F. Haynes
金额:
$362.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-02-08 至 2023-01-31
关键词:
AccountingAdvisory CommitteesAgreementAnimal ModelAntigensB-LymphocytesBudgetsCell LineageClinical TrialsCollaborationsCommunicationContractsDataData AnalysesData ProvenanceDevelopmentEnsureExpenditureExperimental DesignsFundingGlycopeptidesGoalsGrantGuidelinesHIVHIV-1HIV-1 vaccineHumanIACUCImmune responseInfrastructureInstitutional PolicyLeadLettersMaterials TestingMeasuresMessenger RNAMonitorNucleosidesOccupational activity of managing financesOutcomeParticipantPersonnel StaffingPhase I Clinical TrialsPoliciesPolysaccharidesPractice GuidelinesPreparationProductionProtocols documentationPublicationsRegulationReportingResearchResearch PersonnelResourcesRightsRiskSupervisionTestingTimeUnited States Food and Drug AdministrationUnited States National Institutes of HealthUniversitiesVaccine Researchconflict resolutiondata managementdata sharingexpectationexperiencemeetingsmembermonomerprogramsquality assurance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Administrative Core
The IPCAVD Administrative Core will serve to coordinate all scientific and administrative activities of the Duke
IPCAVD, ensuring that the Projects and Cores function well together. A primary activity of the Core will be
monitoring IPCAVD progress relative to milestones and measuring this progress against available funding to
ensure resources are used efficiently. The Core will coordinate the effort of an External Advisory Committee
(EAC) that will review the progress of the Projects and Cores and provide critical guidance for the Program's
direction. Core staff are part of a highly experienced and integrated management team, which will enable
immediate start-up and rapid progress. This teamwork will accelerate advancement toward the Program's
goals, thus maximizing the opportunities to positively impact HIV-1 vaccine research in humans. The Specific
Aims of the Administrative Core are as follows.
Aim 1. Provide overall IPCAVD management, coordination and supervision of the Program.
Aim 2. Ensure timely financial accounting and reporting.
Aim 3. Ensure compliance with all institutional, state, and federal research and CGMP guidelines.
Aim 4. Develop and implement an IPCAVD communication, publication, and data sharing plan.
Aim 5. Provide statistical support for all data analyses.
The IPCAVD Administrative Core will facilitate the successful integration of Project 1, Project 2, and the Animal
Models Core to support the overall Program goal to develop two mRNA clinical trials materials for testing in a
Phase 1 clinical trial in year 5. As an optimally functioning Core, it will support development of nucleoside-
modified mRNAs an important new HIV-1 vaccine platform that potentially can transform the HIV-1 vaccine
field by providing immunogens to initiate bnAb lineages and induce durable immune responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core 1: Administrative Core
-
批准号:10842499
-
项目类别:
-
资助金额:$40.84万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Core 1: Administrative Core
-
批准号:10327520
-
项目类别:
-
资助金额:$67.6万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Project 1: Panbetacoronavirus vaccines
-
批准号:10842502
-
项目类别:
-
资助金额:$109.21万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Project 3: Nucleoside-modified mRNA-LNP vaccine platform
-
批准号:10842504
-
项目类别:
-
资助金额:$93.61万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Project 3: Nucleoside-modified mRNA-LNP vaccine platform
-
批准号:10327525
-
项目类别:
-
资助金额:$190.5万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Design and Development of a Pan-betacoronavirus Vaccine
-
批准号:10842498
-
项目类别:
-
资助金额:$1047.8万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Core 3: Non-human Primate Core
-
批准号:10327522
-
项目类别:
-
资助金额:$448.74万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Project 1: Panbetacoronavirus vaccines
-
批准号:10327523
-
项目类别:
-
资助金额:$190.5万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Core 3: Non-human Primate Core
-
批准号:10842501
-
项目类别:
-
资助金额:$279.88万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Design and Development of a Pan-betacoronavirus Vaccine
-
批准号:10327519
-
项目类别:
-
资助金额:$1752.2万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Core-001
-
批准号:10544855
-
项目类别:
-
资助金额:$120.82万
-
财政年份:2019
-
负责人:Barton F. Haynes
-
依托单位:
Messenger RNA Immunogens for initiation of protective HIV non-neutralizing antibodies
-
批准号:10355426
-
项目类别:
-
资助金额:$387.82万
-
财政年份:2019
-
负责人:Barton F. Haynes
-
依托单位:
Project 1 - Development of mRNA Immunogens for Protective Antibody Induction
-
批准号:10355428
-
项目类别:
-
资助金额:$219.75万
-
财政年份:2019
-
负责人:Barton F. Haynes
-
依托单位:
Administrative Core
-
批准号:10355427
-
项目类别:
-
资助金额:$49.54万
-
财政年份:2019
-
负责人:Barton F. Haynes
-
依托单位:
Induction of protective antibodies for HIV vaccine development
-
批准号:9977914
-
项目类别:
-
资助金额:$2634.79万
-
财政年份:2019
-
负责人:Barton F. Haynes
-
依托单位:
Induction of protective antibodies for HIV vaccine development
-
批准号:10450150
-
项目类别:
-
资助金额:$2789.23万
-
财政年份:2019
-
负责人:Barton F. Haynes
-
依托单位:
Induction of protective antibodies for HIV vaccine development
-
批准号:10656276
-
项目类别:
-
资助金额:$3040.14万
-
财政年份:2019
-
负责人:Barton F. Haynes
-
依托单位:
Messenger RNA immunogens for initiation of HIV V3-glycan neutralizing B cell lineages
-
批准号:10338057
-
项目类别:
-
资助金额:$618.31万
-
财政年份:2018
-
负责人:Barton F. Haynes
-
依托单位:
Project 1: Development of Nucleoside-Modified mRNAs Encoding Sequential HIV-1 Envelopes for Initiation of V3-glycan Neutralizing Antibody Lineages
-
批准号:10338059
-
项目类别:
-
资助金额:$209.95万
-
财政年份:2018
-
负责人:Barton F. Haynes
-
依托单位:
Project 1: Development of Nucleoside-Modified mRNAs Encoding Sequential HIV-1 Envelopes for Initiation of V3-glycan Neutralizing Antibody Lineages
-
批准号:10097987
-
项目类别:
-
资助金额:$9.67万
-
财政年份:2018
-
负责人:Barton F. Haynes
-
依托单位:
海外基金